Search results
2 kwi 2024 · The 3-dose vaccine is recommended for all patients with HIV who are 9 to 45 years old. The 9-valent HPV vaccine should be administered according to the CDC standard schedule for immunocompromised adults, children, and adolescents (a 3-dose regimen over a 6-month period at 0, 2, and 6 months) and should be offered regardless of CD4 cell count.
22 gru 2022 · Vaccination is most effective in patients with early HIV infection and in those on ART who are virologically suppressed and have restored CD4 function. This topic will review the approach to vaccination for vaccine-preventable diseases in persons with HIV.
20 gru 2023 · This Review discusses lessons learned from clinical trials of HIV-1 vaccines, current technologies that are being explored, and future considerations in the development of a safe and effective HIV-1 vaccine.
5 sie 2017 · Vaccination is a critical component for ensuring the ongoing health HIV-infected adults. Since this group may have reduced immune responses and shorter durations of protection post-vaccination, HIV-specific guidelines have been published.
19 lip 2024 · Eligible participants were healthy women (assigned female sex at birth) aged 18–35 years who had had sexual intercourse with a male partner two or more times in the 30 days before screening, were at increased risk of acquiring HIV-1, and were HIV-1-negative and HIV-2-negative.
12 paź 2023 · INTRODUCTION. Over one million new human immunodeficiency virus (HIV) infections occur yearly worldwide, with more than 30,000 annually in the United States. As there are no effective vaccines to prevent HIV transmission, behavioral and biomedical HIV prevention strategies are needed to reduce HIV acquisition.
HIV is a pathogen that has challenged vaccine researchers for over 30 years. Momentous HIV research milestones have been reached in the last decade, particularly in immunogen development. Yet, a working vaccine is still lacking.
